Lupin LimitedNSE: LUPIN

Press Release Jul 01 2025

· Issued by Lupin Limited

Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated July 01, 2025, titled "Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Gel".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases